The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Amyloid β-Protein Is Degraded by Cellular Angiotensin-converting Enzyme (ACE) and Elevated by an ACE Inhibitor
Open accessAbstract
Human genetic data have associated angiotensin-converting enzyme (ACE) with Alzheimer disease (AD), and purified ACE has been reported to cleave synthetic amyloid beta-protein (Abeta) in vitro. Whether deficiency in ACE activity, arising from genetic alteration or pharmacological inhibition, can decrease Abeta degradation and allow Abeta accumulation in intact cells is unknown. We cloned ACE from human neuroblastoma cells and showed that it had posttranslational processing and enzymatic activity typical of the endogenous protease. Cellular expression of ACE promoted degradation of naturally secreted Abeta40 and Abeta42, leading to significant clearance of both species. Using site-directed mutagenesis, we determined that both active sites within ACE contribute to Abeta clearance, and an ACE construct bearing mutations in each catalytic domain had no effect on Abeta levels. Pharmacological inhibition of ACE with a widely prescribed drug, captopril, promoted the accumulation of cell-derived Abeta in the media of beta-amyloid precursor-protein expressing cells. Together, these results show that ACE can lower the levels of secreted Abeta in living cells and that this effect is blocked by inhibiting the protease's activity with an ACE inhibitor. This work, combined with the genetic studies, supports the hypothesis that ACE may modulate the susceptibility to and progression of AD via degradation of Abeta. Our data encourage further analyses of the ACE gene for disease association and raise the question of whether currently prescribed ACE inhibitors could elevate cerebral Abeta levels in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rigat, B., Hubert, C., Alhenc-Gelas, F., Cambien, F., Corvol, P., & Soubrier, F. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114844 · Cited by 3,767
Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., & Selkoe, D. J. (1992) · Nature · doi:10.1038/360672a0 · Cited by 1,757
Self-citationClinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial
Gilman, S., Koller, M., Black, R. S., Jenkins, L., Griffith, S. G., Fox, N. C., Eisner, L., Kirby, L., Rovira, M. B., Forette, F., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000159740.16984.3c · Cited by 1,329
Farris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E. A., Frosch, M. P., Eckman, C. B., Tanzi, R. E., Selkoe, D. J., & Guénette, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0230450100 · Cited by 1,286
Self-citationDeciphering the Molecular Basis of Memory Failure in Alzheimer's Disease
Walsh, D. M., & Selkoe, D. J. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.010 · Cited by 1,207
Self-citationMetabolic Regulation of Brain Aβ by Neprilysin
Iwata, N., Tsubuki, S., Takaki, Y., Shirotani, K., Lu, B., Gerard, N. P., Gerard, C., Hama, E., Lee, H.-J., & Saido, T. C. (2001) · Science · doi:10.1126/science.1059946 · Cited by 961
Antibodies against β-Amyloid Slow Cognitive Decline in Alzheimer's Disease
Hock, C., Konietzko, U., Streffer, J. R., Tracy, J., Signorell, A., Müller-Tillmanns, B., Lemke, U., Henke, K., Moritz, E., Garcia, E., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00294-0 · Cited by 777
Leissring, M. A., Farris, W., Chang, A. Y., Walsh, D. M., Wu, X., Sun, X., Frosch, M. P., & Selkoe, D. J. (2003) · Neuron · doi:10.1016/s0896-6273(03)00787-6 · Cited by 719
Self-citation(1997) · doi:10.1073/pnas.94.4.1550 · Cited by 535
Vekrellis, K., Ye, Z., Qiu, W. Q., Walsh, D., Hartley, D., Chesneau, V., Rosner, M. R., & Selkoe, D. J. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-05-01657.2000 · Cited by 495
Self-citationThe two homologous domains of human angiotensin I-converting enzyme are both catalytically active
Wei, L., Alhenc-Gelas, F., Corvol, P., & Clauser, E. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31543-6 · Cited by 383
Hu, J., Igarashi, A., Kamata, M., & Nakagawa, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104068200 · Cited by 360
The Plasmin System Is Induced by and Degrades Amyloid-β Aggregates
Tucker, H. M., Kihiko, M., Caldwell, J. N., Wright, S., Kawarabayashi, T., Price, D., Walker, D., Scheff, S., McGillis, J. P., Rydel, R. E., et al. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-03937.2000 · Cited by 309
Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease
Kehoe, P. G., Russ, C., McIlroy, S., Williams, H., Holmans, P., Holmes, C., Liolitsa, D., Vahidassr, D., Powell, J., McGleenon, B., et al. (1999) · Nature Genetics · doi:10.1038/5009 · Cited by 260
Wei, L., Clauser, E., Alhenc-Gelas, F., & Corvol, P. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42224-7 · Cited by 256
Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression
Ohrui, T., Tomita, N., Sato-Nakagawa, T., Matsui, T., Maruyama, M., Niwa, K., Arai, H., & Sasaki, H. (2004) · Neurology · doi:10.1212/01.wnl.0000140705.23869.e9 · Cited by 246
The angiotensin converting enzyme (ACE)
Coates, D. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00309-6 · Cited by 242
Alzheimer's Disease β-Amyloid Peptide Is Increased in Mice Deficient in Endothelin-converting Enzyme
Eckman, E. A., Watson, M., Marlow, L., Sambamurti, K., & Eckman, C. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200642200 · Cited by 218
Savaskan, E., Hock, C., Olivieri, G., Bruttel, S., Rosenberg, C., Hulette, C., & Müller-Spahn, F. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00259-1 · Cited by 217
Alzheimer Disease: Mechanistic Understanding Predicts Novel Therapies
Selkoe, D. J. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-8-200404200-00047 · Cited by 208
Self-citationLehmann, D. J., Cortina-Borja, M., Warden, D. R., Smith, A. D., Sleegers, K., Prince, J. A., van Duijn, C. M., & Kehoe, P. G. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi202 · Cited by 199
Hooper, N. M., & Turner, A. J. (1987) · Biochemical Journal · doi:10.1042/bj2410625 · Cited by 189
LEISSRING, M. A., FARRIS, W., WU, X., CHRISTODOULOU, D. C., HAIGIS, M. C., GUARENTE, L., & SELKOE, D. J. (2004) · Biochemical Journal · doi:10.1042/bj20041081 · Cited by 162
Self-citationThe Broad Substrate Specificity of Human Angiotensin I Converting Enzyme
Skidgel, R. A., & Erdös, E. G. (1987) · Clinical and Experimental Hypertension. Part A: Theory and Practice · doi:10.3109/10641968709164184 · Cited by 161
Arregui, A., Perry, E. K., Rossor, M. N., & Tomlinson, B. E. (1982) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1982.tb07930.x · Cited by 160
An improved fluorometric assay of rat serum and plasma converting enzyme.
Santos, R. A., Krieger, E. M., & Greene, L. J. (1985) · Hypertension · doi:10.1161/01.hyp.7.2.244 · Cited by 160
Oba, R., Igarashi, A., Kamata, M., Nagata, K., Takano, S., & Nakagawa, H. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03912.x · Cited by 140
Angiotensin-Converting Enzyme Is Involved in Outside-In Signaling in Endothelial Cells
Kohlstedt, K., Brandes, R. P., Müller‐Esterl, W., Busse, R., & Fleming, I. (2003) · Circulation Research · doi:10.1161/01.res.0000107195.13573.e4 · Cited by 136
Alzheimer disease risk and genetic variation in ACE: A meta-analysis
Elkins, J. S., Douglas, V. C., & Johnston, S. C. (2004) · Neurology · doi:10.1212/01.wnl.0000106823.72493.ff · Cited by 132
Barnes, N. M., Cheng, C. H. K., Costall, B., Naylor, R. J., Williams, T. J., & Wischik, C. M. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90584-d · Cited by 131
Proteolytic release of human angiotensin-converting enzyme. Localization of the cleavage site.
Beldent, V., Michaud, A., Wei, L., Chauvet, M. T., & Corvol, P. L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74332-4 · Cited by 129
Fuchs, S., Xiao, H., Cole, J. M., Adams, J. W., Frenzel, K. E., Michaud, A., Zhao, H., Keshelava, G., Capecchi, M. R., Corvol, P. L., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400149200 · Cited by 104
Farris, W., Leissring, M. A., Hemming, M. L., Chang, A. Y., & Selkoe, D. J. (2005) · Biochemistry · doi:10.1021/bi0476578 · Cited by 91
Self-citationKohlstedt, K., Busse, R., & Fleming, I. (2004) · Hypertension · doi:10.1161/01.hyp.0000150159.48992.11 · Cited by 79
Woodman, Z., Oppong, S. Y., Sarah, C. O. O. K., Hooper, N. M., Schwager, S. L. U., BRANDT, W. F., Ehlers, M. R., & Sturrock, E. D. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3470711 · Cited by 76
Mice Lacking Endothelial Angiotensin-Converting Enzyme Have a Normal Blood Pressure
Cole, J., Quach, D. L., Sundaram, K., Corvol, P., Capecchi, M., & Bernstein, K. (2002) · Circulation Research · doi:10.1161/hh0102.102360 · Cited by 74
ACE I/D polymorphism is a risk factor of Alzheimer's disease but not of vascular dementia
Kölsch, H., Jessen, F., Freymann, N., Kreis, M., Hentschel, F., Maier, W., & Heun, R. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.11.062 · Cited by 68
ACE gene is associated with Alzheimer's disease and atrophy of hippocampus and amygdala
Sleegers, K., den Heijer, T., van Dijk, E. J., Albert Hofman, D., Bertoli‐Avella, A. M., Koudstaal, P. J., Breteler, M. M. B., & van Duijn, C. M. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.09.011 · Cited by 61
Binevski, P. V., Sizova, E. A., Pozdnev, V. F., & Kost, O. A. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00825-1 · Cited by 60
Katzov, H., Bennet, A. M., Kehoe, P. G., Wiman, B., Gatz, M., Blennow, K., Lenhard, B., Pedersen, N. L., Fairé, U. D., & Prince, J. A. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh286 · Cited by 49
Lendon, C. L., Thaker, U., Harris, J. M., McDonagh, A. M., Lambert, J., Chartier‐Harlin, M., Iwatsubo, T., Pickering-Brown, S. M., & Mann, D. M. A. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00553-0 · Cited by 44
Plasmin deficiency does not alter endogenous murine amyloid beta levels in mice
Tucker, H. M., Simpson, J. F., Kihiko‐Ehmann, M., Younkin, L. H., McGillis, J. P., Younkin, S. G., Degen, J. L., & Estus, S. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.07.011 · Cited by 38
Dementia and antihypertensive treatment
ger, W. B., Forette, F. O., & Staessen, J. A. (2004) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200403000-00011 · Cited by 24
Donepezil therapy for neuropsychiatric symptoms in AD: Methods make the message
Herrmann, N., & Knopman, D. S. (2004) · Neurology · doi:10.1212/01.wnl.0000134774.19232.09 · Cited by 5
Cited by
The Genetics of Alzheimer's Disease
Bertram, L., & Tanzi, R. E. (2012) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-385883-2.00008-4 · Cited by 760
Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses
Bertram, L., & Tanzi, R. E. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2494 · Cited by 747
The genetics of Alzheimer disease
Tanzi, R. E. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006296 · Cited by 727
Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease
Barage, S. H., & Sonawane, K. D. (2015) · Neuropeptides · doi:10.1016/j.npep.2015.06.008 · Cited by 579
Miners, J. S., Baig, S., Palmer, J., Palmer, L. E., Kehoe, P. G., & Love, S. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00132.x · Cited by 381
Metadata
- Authors
- Hemming, M. L., & Selkoe, D. J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-11
- Volume
- 280
- Issue
- 45
- Pages
- 37644-37650
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1999061258
- Cited by
- 332
- References
- 44
- FWCI
- 9.85
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.